Sonia Friedman, M.D., is an associate professor of medicine at Harvard Medical School and director of women’s health at the Crohn’s and Colitis Center at Brigham and Women’s Hospital. She is an expert on inflammatory bowel disease (IBD), and her research interests include IBD and fertility and pregnancy. She is the co-author of the chapter on IBD in Harrison’s Principles of Internal Medicine. Dr. Friedman received her M.D. from Yale School of Medicine, was a medical resident at the Hospital of the University of Pennsylvania, and completed a fellowship in gastroenterology at Mount Sinai Medical Center in New York, where she developed her interest in IBD.
Lisa I. Iezzoni
Lisa I. Iezzoni, M.D., M.Sc., is a professor of medicine at Harvard Medical School based at the Health Policy Research Center at the Mongan Institute at Massachusetts General Hospital. She has conducted health services research for more than 35 years, focusing on two primary areas: risk adjustment methods for predicting cost and clinical outcomes of care, and health care experiences and outcomes of persons with disabilities. After 16 years as co-director of research in the Division of General Medicine and Primary Care at Boston’s Beth Israel Deaconess Medical Center, Dr. Iezzoni joined the then Institute for Health Policy as associate director in 2006, and served as director of the newly named Health Policy Research Center from 2009 to 2018. She served from 2008 to 2010 on the U.S. Secretary's Advisory Committee on Health Promotion and Disease Prevention Objectives for 2020. She has led health policy-related studies for the Agency for Healthcare Research and Quality, the Health Care Financing Administration, the NIH, and private foundations. She currently receives NIH funding for two projects focused on persons with disabilities. She edited Risk Adjustment for Measuring Health Care Outcomes, now in its fourth edition. She wrote When Walking Fails and was co-author of More Than Ramps: A Guide to Improving Health Care Quality and Access for People with Disabilities. She is a member of the National Academy of Medicine. Dr. Iezzoni received her M.Sc. from the Harvard School of Public Health's Health Policy and Management program and her M.D. from Harvard Medical School.
Andrea M. Knight
Andrea M. Knight, M.D., M.S.C.E., is an assistant professor of pediatrics at the University of Toronto, and a staff physician in the Division of Rheumatology at the Hospital for Sick Children in Toronto, where she is an associate scientist in the Neurosciences and Mental Health Program of the Research Institute. She is also an adjunct assistant professor of pediatrics in the associated faculty of the Perelman School of Medicine at the University of Pennsylvania, and a faculty scholar at PolicyLab at Children’s Hospital of Philadelphia (CHOP). Dr. Knight’s research focuses on mental health in youth with rheumatologic conditions, with an emphasis on neuropsychiatric function in childhood-onset systemic lupus erythematosus (cSLE). She has investigated the burden of psychiatric morbidity and strategies to improve comprehensive care for youth with SLE and other rheumatologic disease. She is also investigating the impact of cSLE on brain structure, function, and development. Dr. Knight received her M.D. from the College of Physicians and Surgeons of Columbia University. She completed a residency in pediatrics and a fellowship in pediatric rheumatology at CHOP. She earned her M.S.C.E. from the University of Pennsylvania.
Scott M. Lieberman
Scott M. Lieberman, M.D., Ph.D., is associate professor of pediatrics in the Division of Rheumatology, Allergy and Immunology at Carver College of Medicine, University of Iowa. His research goals are to understand the earliest immunologic events in the development of organ-specific autoimmunity to identify potential targets for better diagnosis and treatment of these diseases. The main focus of his laboratory is the role of T cells in the initiation of lacrimal and salivary gland autoimmunity characteristic of Sjögren’s disease. He currently has NIH funding for a study on the role of cytokines in T-cell dysregulation in lacrimal gland autoimmunity. He also cares for children with rheumatic diseases and participates in efforts to better understand Sjögren’s in children through an international collaborative workgroup. He has co-authored several book chapters on rheumatic disease manifestations in children including, most recently, the chapter on Sjögren’s in children in Sjögren’s Syndrome: A Clinical Handbook (Elsevier). He received the Arthritis Foundation’s Stewart J. McCracken Award for excellence in the field of arthritis research, and he was awarded an American Association of Immunologists Careers in Immunology Fellowship. He earned his Ph.D. in immunology and his M.D. at the Albert Einstein College of Medicine. He performed a residency in pediatrics (ABP Special Alternative Pathway) at the Children’s Hospital of Philadelphia, where he also completed a fellowship in pediatric rheumatology.
Michael D. Lockshin
Michael D. Lockshin, M.D., is the director of the Barbara Volcker Center for Women and Rheumatic Disease at Hospital for Special Surgery (HSS) in New York and professor of medicine and obstetrics-gynecology at Weill Cornell Medicine. As a medical student he cared for a seriously ill pregnant woman with systemic lupus erythematosus (SLE), and he has focused his career on patients with this disease. He was one of the first physicians to associate the newly discovered antiphospholipid antibody with pregnancy complications. Dr. Lockshin has had a long-standing interest in the overlap of autoimmune diseases such as SLE, multiple sclerosis, and thyroid disease, and in sex differences in disease incidence. He is also working to create consensus to systematize approaches for confronting diagnostic uncertainty for patients with conditions that do not fall within clear diagnostic criteria. A member of the faculty of Weill Cornell Medical College and a staff rheumatologist at HSS and New York Hospital (now Weill Cornell Medicine) from 1970 to 1989, he became Extramural director, then acting director, of the National Institute of Arthritis and Musculoskeletal and Skin Diseases in 1989. He returned to HSS in 1997 to head the Barbara Volcker Center. He also served as an Epidemic Intelligence Service Officer in the U.S. Public Health Service of the Communicable Disease Center (now Centers for Disease Control), where he focused on environmental causes of rheumatic illnesses. Dr. Lockshin has served as editor-in-chief of Arthritis and Rheumatism, rheumatology's premier journal. He has served on several National Academy of Medicine committees. Dr. Lockshin received his M.D. from Harvard Medical School, and he completed his medical residency at Second (Cornell) Medical Service at Bellevue Hospital and Memorial Sloan Kettering Cancer Center and his rheumatology fellowship at Columbia-Presbyterian Hospital (now New York-Presbyterian/Columbia University Irving Medical Center).
Jill M. Norris
Jill M. Norris, Ph.D., M.P.H., is professor and chair of the Department of Epidemiology in the Colorado School of Public Health at the University of Colorado Denver. Dr. Norris’ research has focused on the relationship between diet and other environmental exposures and the development of autoimmune diseases—including type 1 diabetes, celiac disease, rheumatoid arthritis, and lupus—using longitudinal cohort studies in which genetically at-risk individuals are followed for the appearance of autoantibodies and subsequent progression to clinical disease. She has taken part in multiple NIH-funded studies, and she is currently involved in a project on type 1 diabetes. She was a contributor to Diabetes in America (3rd ed., 2016–2018), published by the National Institute of Diabetes and Digestive and Kidney Diseases. She received her M.P.H. and Ph.D. from the University of Pittsburgh Graduate School of Public Health.
Emily C. Somers
Emily C. Somers, Ph.D., Sc.M., is associate professor of internal medicine-rheumatology, of environmental health sciences, and of obstetrics and gynecology at the University of Michigan Schools of Medicine and Public Health. She specializes in autoimmune diseases, particularly lupus, and her work spans epidemiologic, clinical, and translational research, including the design and conduct of clinical trials. She has performed leading population-based studies of lupus epidemiology in the United Kingdom, Denmark, and United States. Major research interests include epidemiology, comorbidities, and public health impact of rheumatic and autoimmune diseases; clinical epidemiology of systemic lupus erythematosus (SLE), including studies of subclinical cardiovascular disease in SLE and gene expression-based molecular classification of lupus nephritis; and pharmacoepidemiologic issues in autoimmune disease. Her work in pharmacoepidemiology has characterized risk of drug-induced lupus, as well as developmental outcomes among offspring of mothers whose pregnancies occurred in the presence of SLE. She has received NIH funding, and currently receives CDC funding, for research investigating early life exposures to metals and development of immune dysfunction. She received her Sc.M. and Ph.D. in epidemiology from the London School of Hygiene and Tropical Medicine, and from the Johns Hopkins School of Hygiene and Public Health, respectively.
Barbara G. Vickrey, M.D., M.P.H., is professor and System Chair of Neurology at the Icahn School of Medicine at Mount Sinai. She specializes in translating clinical evidence into improvements in routine medical practice to improve patient health. Among her accomplishments are demonstrating that collaboration among health care systems, community organizations, and caregivers can improve quality of care and outcomes for dementia patients. She has designed health-care delivery innovations ranging from better control of post-stroke risk factors in underserved populations to new ways to care for veterans with Parkinson's disease. Dr. Vickrey is a member of the National Academy of Medicine. Dr. Vickrey served for 25 years on the faculty of the University of California, Los Angeles (UCLA), where she was professor of neurology and director of the departmental Health Services Research Program. She was also associate director for research at the Greater Los Angeles Veterans Administration Parkinson’s Disease Research, Education and Clinical Center. Dr. Vickrey earned her M.D. at Duke University School of Medicine and her M.P.H. at the UCLA School of Public Health. She completed postgraduate clinical training in medicine and neurology at the University of Washington in Seattle, and then research fellowships in the Robert Wood Johnson Clinical Scholars Program at UCLA and the RAND/UCLA Center for Health Policy Study.